Coronavirus (COVID-19) and Prostate Cancer

Updated: Nov 21, 2020

For 'Low' and 'Intermediate' risk prostate cancer, surveillance is being offered. In certain circumstances following a discussion at the multi-disciplinary team meeting, Intermediate risk prostate cancer patients have been offered 'Anti Androgens'. A database is being maintained to keep track of all patients on the modified pathway.


Slide showing prostate cancer in biopsy sample.
Prostate Cancer



'High Risk' prostate cancer are being offered Anti-Androgens and Radiotherapy. Once the crises abates then surgical treatment will commence. Regular Prostate Specific Antigen (PSA) monitoring is still being carried out and remote consultations taking place to communicate the results.


To protect patients with cancer, who are likely to be vulnerable to the virus, urologists are embracing telemedicine to allow most patients to stay home. Around 80% of our clinics are virtual, thereby maintaining a balance between patient contact and disease prevention.

8 views0 comments